APA (7th ed.) Citation

Luedtke, R., & Mach, R. (2003). Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders. Current pharmaceutical design, 9(8), 643-671. https://doi.org/10.2174/1381612033391199

Chicago Style (17th ed.) Citation

Luedtke, Robert, and Robert Mach. "Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders." Current Pharmaceutical Design 9, no. 8 (2003): 643-671. https://doi.org/10.2174/1381612033391199.

MLA (9th ed.) Citation

Luedtke, Robert, and Robert Mach. "Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders." Current Pharmaceutical Design, vol. 9, no. 8, 2003, pp. 643-671, https://doi.org/10.2174/1381612033391199.